| Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint … DF Hanley, RE Thompson, M Rosenblum, G Yenokyan, K Lane, N McBee, ... The Lancet 393 (10175), 1021-1032, 2019 | 683 | 2019 |
| Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial DF Hanley, K Lane, N McBee, W Ziai, S Tuhrim, KR Lees, J Dawson, ... The Lancet 389 (10069), 603-611, 2017 | 428 | 2017 |
| Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edema WA Mould, JR Carhuapoma, J Muschelli, K Lane, TC Morgan, NA McBee, ... Stroke 44 (3), 627-634, 2013 | 399 | 2013 |
| Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial DF Hanley, RE Thompson, J Muschelli, M Rosenblum, N McBee, K Lane, ... The Lancet Neurology 15 (12), 1228-1237, 2016 | 352 | 2016 |
| Preliminary findings of the minimally-invasive surgery plus rtPA for intracerebral hemorrhage evacuation (MISTIE) clinical trial T Morgan, M Zuccarello, R Narayan, P Keyl, K Lane, D Hanley Cerebral Hemorrhage, 147-151, 2008 | 318 | 2008 |
| Early outpatient treatment for Covid-19 with convalescent plasma DJ Sullivan, KA Gebo, S Shoham, EM Bloch, B Lau, AG Shenoy, ... New England Journal of Medicine 386 (18), 1700-1711, 2022 | 223 | 2022 |
| Early identification of patients at risk for symptomatic vasospasm after aneurysmal subarachnoid hemorrhage AI Qureshi, GY Sung, AY Razumovsky, K Lane, RN Straw, JA Ulatowski Critical care medicine 28 (4), 984-990, 2000 | 207 | 2000 |
| Preliminary report of the clot lysis evaluating accelerated resolution of intraventricular hemorrhage (CLEAR-IVH) clinical trial T Morgan, I Awad, P Keyl, K Lane, D Hanley Cerebral Hemorrhage, 217-220, 2008 | 196 | 2008 |
| Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial N Naff, MA Williams, PM Keyl, S Tuhrim, MR Bullock, SA Mayer, W Coplin, ... Stroke 42 (11), 3009-3016, 2011 | 194 | 2011 |
| ICES (Intraoperative Stereotactic Computed Tomography-Guided Endoscopic Surgery) for brain hemorrhage: a multicenter randomized controlled trial P Vespa, D Hanley, J Betz, A Hoffer, J Engh, R Carter, P Nakaji, C Ogilvy, ... Stroke 47 (11), 2749-2755, 2016 | 168 | 2016 |
| The Modified Graeb Score: an enhanced tool for intraventricular hemorrhage measurement and prediction of functional outcome TC Morgan, J Dawson, D Spengler, KR Lees, C Aldrich, NK Mishra, ... Stroke 44 (3), 635-641, 2013 | 158 | 2013 |
| A multicenter, randomized, double-blinded, placebo-controlled phase III study of Clot Lysis Evaluation of Accelerated Resolution of Intraventricular Hemorrhage (CLEAR III) WC Ziai, S Tuhrim, K Lane, N McBee, K Lees, J Dawson, K Butcher, ... International Journal of Stroke 9 (4), 536-542, 2014 | 137 | 2014 |
| Linkage of the locus for cerebral cavernous hemangiomas to human chromosome 7q in four families of Mexican-American descent MH Polymeropoulos, O Hurko, F Hsu, J Rubenstein, S Basnet, K Lane, ... Neurology 48 (3), 752-757, 1997 | 126 | 1997 |
| Surgical performance determines functional outcome benefit in the minimally invasive surgery plus recombinant tissue plasminogen activator for intracerebral hemorrhage … IA Awad, SP Polster, J Carrión-Penagos, RE Thompson, Y Cao, A Stadnik, ... Neurosurgery 84 (6), 1157-1168, 2019 | 117 | 2019 |
| Occurrence and impact of intracranial pressure elevation during treatment of severe intraventricular hemorrhage WC Ziai, E Melnychuk, CB Thompson, I Awad, K Lane, DF Hanley Critical care medicine 40 (5), 1601-1608, 2012 | 89 | 2012 |
| Bleeding and infection with external ventricular drainage: a systematic review in comparison with adjudicated adverse events in the ongoing Clot Lysis Evaluating Accelerated … M Dey, A Stadnik, F Riad, L Zhang, N McBee, C Kase, JR Carhuapoma, ... Neurosurgery 76 (3), 291-301, 2015 | 86 | 2015 |
| Atorvastatin treatment of cavernous angiomas with symptomatic hemorrhage exploratory proof of concept (AT CASH EPOC) trial SP Polster, A Stadnik, AL Akers, Y Cao, GA Christoforidis, MD Fam, ... Neurosurgery 85 (6), 843-853, 2019 | 71 | 2019 |
| Maintenance daily oral etoposide versus no further therapy following induction chemotherapy with etoposide plus ifosfamide plus cisplatin in extensive small-cell lung cancer: a … NH Hanna, AB Sandler, PJ Loehrer Sr, R Ansari, SH Jung, K Lane, ... Annals of oncology 13 (1), 95-102, 2002 | 69 | 2002 |
| Surgical performance in minimally invasive surgery plus recombinant tissue plasminogen activator for intracerebral hemorrhage evacuation phase III clinical trial MD Fam, D Hanley, A Stadnik, HA Zeineddine, R Girard, M Jesselson, ... Neurosurgery 81 (5), 860-866, 2017 | 60 | 2017 |
| Intracranial hypertension and cerebral perfusion pressure insults in adult hypertensive intraventricular hemorrhage: occurrence and associations with outcome WC Ziai, CB Thompson, S Mayo, N McBee, WD Freeman, R Dlugash, ... Critical care medicine 47 (8), 1125-1134, 2019 | 56 | 2019 |
